university website

J.M. de Vries (Juna), E. Kuperus (Esther), M. Hoogeveen-Westerveld (Marianne), M.A. Kroos (Marian), S.C.A. Wens (Stephan), M. Stok (Merel), N.A.M.E. van der Beek (Nadine), M.E. Kruijshaar (Michelle), D. Rizopoulos (Dimitris), P.A. van Doorn (Pieter), et al. A.T. van der Ploeg (Ans) and W.W.M.P. Pijnappel (Pim)

2017-11-01

Response to Herbert et al.

Publication

Publication

["Response to de Vries et al." Genet Med, advance online publication, May 11, 2017; doi:10.1038/gim.2017.48]

Genetics in Medicine , Volume 19 - Issue 11 p. 1282- 1283

To the Editor:
We thank Herbert et al. for their interest in our work. Their laboratory has shown to be instrumental in studying the effects of enzyme replacement therapy (ERT) in infants with Pompe disease. However, there are some misunderstandings about our study on adult Pompe patients and antibody formation. Below we explain these in detail.

Additional Metadata
Persistent URL doi.org/10.1038/gim.2017.49, hdl.handle.net/1765/102816
Journal Genetics in Medicine
Organisation Department of Clinical Genetics
Citation
de Vries, J., Kuperus, E., Hoogeveen-Westerveld, M., Kroos, M., Wens, S., Stok, M., … Pijnappel, P. (2017). Response to Herbert et al. Genetics in Medicine, 19(11), 1282–1283. doi:10.1038/gim.2017.49
Free Full Text ( Final Version )


User Publication Person Organisation Collection
Close